Endocrinology Flashcards

1
Q

List the causes of primary amenorrhoea

A

Never had a period

3 causes

> Genitourinary abnormalities

> > Congenital absence of uterus, cervix or vagina
> Rokitansky syndrome
> Androgen insensitivity syndrome

> Chromosomal abnormalities
> Turner’s syndrome

> Secondary hypogonadism (pituitary/hypothalamic causes)

> > Kallmann syndrome
Pituitary disease
Hypothalamic amenorrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the causes of secondary amenorrhoea

A

No periods for 6 months

> Uterine
> Ashermans syndrome - adhesions in the uterus preventing normal menstruation

> Ovarian
> PCOS
> Premature ovarian failure

> Pituitary
> Prolactinoma
> Pituitary tumour

> Hypothalamic
> Weight loss
> Stress
> Drugs e.g. opiates

> Other
> Psychological: pregnancy, lactation
> Iatrogenic: OCP
> Thyroid dysfunction
> Hyperandrogenism
» Cushing’s syndrome
» CAH
» Adrenal or ovarian tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define hirsutism and list its causes

A

Excess hair growth in a male pattern due to increased androgens and increased skin sensitivity due to androgens

Causes

> Ovarian
> PCOS
> Androgen-secreting tumour

> Adrenal
> Congenital adrenal hypertrophy
> Androgen secreting tumour

> Idiopathic
> Normal investigations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the clinical presentation and investigations used to diagnose PCOS

A

Clinical presentation
> Anovulation
» Amenorrhoea/oligomenorrhoea

> Hyperandrogenism
> Hirsutism
> Acne
> Alopecia

> Investigations
> Confirm profile of PCOS
» Testosterone, androstenedione, DHEAs
» SHBG
» FSH/LH

> > Assess for other features
> Type 2 diabetes
> Abnormal lipids

> > Exclude other pathologies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the pathophysiology of PCOS

A

> Elevated LH:FSH ratio; 2:1 is diagnostic

> Increased androgen production from theca cells under influence of LH

> Decreased sex hormone binding globulin (SHBG); free testosterone is biologicall active - hyperandrogenism, hyperinsulinaemia

> Insulin resistance
> Insulin stimulates theca cells, reduces hepatic production of SHBG and increases circulating androgens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the treatment of PCOS

A

COCP – Dianette ideal
> Ovarian androgen suppression

Corticosteroids
> Adrenal androgen suppression

Spironolactone, cyproterone acetate
> Androgen receptor antagonist

Finasteride
> 5 alpha reductase inhibitor

Metformin
> Insulin sensitiser
» Give if at high risk of diabetes

Eflornithine
> Topical inhibitor

Weight loss
> Diet & lifestyle changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define hypoglycaemia and list associated symptoms

A

People with diabetes – plasma glucose <4 mmol/L

People without diabetes – plasma glucose <2.5 mmol/L with symptoms

Hypoglycaemic symptoms

> Autonomic
> Sweating
> Palpitations
> Pallor
> Tremors
> Nausea
> Irritability
> Hunger

> Neuroglycopaenic (later)
> Inability to concentrate
> Confusion
> Drowsiness
> Personality change
> Slurred speech
> Incoordination
> Weakness
> Dizziness
> Vision impairment
> Headache
> Seizures
> Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the causes of hypoglycaemia

A

Excess insulin
> Erroneous injection of insulin or deliberate overdose

Increased sensitivity to insulin
> Exercise and weight loss

Reduced carbohydrate intake/increased metabolic demand
> Irregular or missed meal
> Malabsorption e.g. coeliac
> Eating disorder

Reduced ability to detect hypoglycaemia
> Impaired awareness, dementia, older age
> Long duration T1DM / insulin-treated T2DM
> Sleep

Reduced gluconeogenesis and glycogen reserves
> Alcohol
> CKD or advanced liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the management of hypoglycaemia

A

Biochemical or symptomatic hypoglycaemia – self-treated

> All glucose levels <4.0 mmol/l are treated – 4 is the floor

> Oral fast-acting carbohydrate (10-15g) is taken as glucose drink or tablets or confectionery

> Do not omit basal insulin

Severe – external help required

> IV 75 mL 20% dextrose over 15 mins + 15g
OR IM glucagon (1mg)

> If patient is conscious and able to swallow
> Oral refined glucose as drinks (25g) or sweets OR apply glucose gel/jam/honey to buccal mucosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe Whipple’s triad

A

Symptoms consistent with hypoglycaemia

Low plasma glucose concentration

Relief of those symptoms after the plasma glucose level is raised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the investigations for hypoglycaemia

A

Post-prandial
> Mixed meal test up to 5 hours
Patient fasts overnight
Have a mixed meal – usually similar to what the patient said caused symptoms i.e., measured quantity of ice cream
Take blood every 30 minutes for approx. 5 hours
Observe for hypo signs/symptoms

72h fast
> Complete at plasma glucose 2.5 mmol/L with symptoms, 72h elapsed or if plasma glucose is <3 if Whipple’s triad has previously been documented

Bloods
> Glucose
> Insulin
> C peptide
> SU screen
> Beta hydroxybutyrate (low in insulinoma)
> Pro-insulin low with exogenous insulin
> Insulin antibodies

Endogenous hyperinsulinaemic hypoglycaemia

> Localising studies: CT / MRI of pancreas, endoscopic ultrasound (EUS)

> Arterial calcium stimulation: distinguishes focal (insulinoma) from diffuse disease (nesidioblastosis / islet cell hypertrophy)

> If negative imaging, injection of calcium gluconate into gastroduodenal, splenic and superior mesenteric arteries with sampling of hepatic venous insulin levels (double or tripling of basal insulin concentrations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List causes of spontaneous hypoglycaemia

A

Pancreatic
> Insulinoma
> Non-insulinoma pancreatogenic hypoglycaemia (NIPH) - Nesidioblastosis
> MEN1

Non-islet cell tumour hypoglycaemia
> IGF-II secreting tumours
» Mesenchymal tumours
» Carcinomas of the liver, stomach and adrenals

> Lymphoma, myeloma, leukaemias
Metastatic cancer

Autoimmune hypoglycaemia
> Autoimmune insulin syndrome
> Anti-insulin receptor

Reactive hypoglycaemia
> Post-gastric surgery
> Alcohol provoked reactive hypoglycaemia

Drug-induced
> Hypoglycaemic drugs
> Beta blockers
> Heparin
> Trimethoprim

Organ failure
> Severe liver disease
> End-stage renal disease and renal dialysis
> Congestive cardiac failure

Endocrine disease
> Hypopituitarism
> Adrenal failure
> Hypothyroidism

Inborn errors of metabolism

Miscellaneous
> Sepsis
> Starvation
> Anorexia nervosa
> Total parenteral nutrition
> Severe excessive exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the physiological regulation of calcium

A

PTH
> Secreted in response to low free calcium
> Causes
» Bone resorption
» Reabsorption of calcium from renal tubules
» Activation of vitamin D
» Increased urinary excretion of phosphate

1,25 OH vitamin D
> Absorption of calcium from GI tract (duodenum, jejunum)

Calcitonin
> Produced by medullary C cells (parafollicular) in thyroid gland
> Inhibits bone resorption by osteoclasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the symptoms of hypercalcaemia

A

Neuro
> Lethargy
> Confusion
> Irritability
> Depression
> Coma

MSK
> Bone pain
> Muscle weakness
> Osteopenia / osteoporosis

GI
> Anorexia
> Nausea
> Constipation
> Abdominal pain
> May be secondary to pancreatitis or peptic ulcers

Renal
> Thirst
> Polyuria
> Renal calcium deposition
> Lead to renal calculi formation and nephrocalcinosis

Cardiac
> Arrhythmias – shortened QTc interval; tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe how the severity of hypercalcaemia is assessed

A

2.20-2.60 mmol/L
> Normal range of corrected calcium

<3.0 mmol/L
> Often asymptomatic

3.0-3.5 mmol/L
> May be symptomatic, prompt treatment is indicated

> 3.5 mmol/L
Urgent correction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the causes of hypercalcaemia

A

Detectable / high PTH: PTH-dependent causes

> Primary hyperparathyroidism

> > Adenoma of parathyroid gland
> Increased bone resorption and GI absorption
> Raised calcium and PTH

> > Hyperplasia

> Tertiary hyperparathyroidism – renal failure

> Familial hypocalciuric hypercalcaemia (FHH)
> High calcium detected by parathyroid gland as normal so patient has normal detectable PTH

Undetectable PTH: PTH-independent causes

> Secondary hyperparathyroidism - malignancy

> > PTH-related peptide, similar to PTH, will raise calcium levels
> Raised calcium but PTH will be suppressed
> Lung, breast and multiple myeloma are commonest tumours
> Also seen in bone metastases due to direct osteolysis

Rarer causes
> Drugs – thiazides
> Endocrine – thyrotoxicosis, Addison’s
> Bone – immobilisation

> Vitamin D excess
> Granulomatous disorders – sarcoidosis, tuberculosis
> Lymphomas
> Iatrogenic vitamin D metabolite excess

> Renal
> Recovery from rhabdomyolysis
> Diuretic phase of renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the management of hypercalcaemia

A

Conservative
> Adequate hydration – IV 0.9% NaCl
> Bisphosphonates e.g. zolendronic acid – reduce bone resorption
> Glucocorticoids – reduce vitamin D production

> If PTH-dependent
> Calcimimetics e.g. cinacalcet – reduce PTH production
> Calcitonin – increases calcium excretion

Surgical - parathyroidectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the anatomy of the adrenal gland

A

3 main layers

> Capsule

> Cortex (GFR)

> > Zona glomerulosa: mineralocorticoids – aldosterone

> > Zona fasciculata: glucocorticoids - cortisol

> > Zona reticularis: androgens – androstenedione, DHEA

> Medulla : chromaffin cells – catecholamines e.g. adrenaline, noradrenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the function of aldosterone

A

Activation of mineralocorticoid receptor on epithelial surface of renal tubule cells in cortical collecting duct (CCD)

Activation of sodium channel (ENaC) allowing sodium retention

Potassium is excreted to maintain electrochemical neutrality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the regulation of cortisol production

A

CRH secreted from hypothalamus in response to low plasma cortisol

CRH stimulates ACTH release from anterior pituitary

ACTH stimulates cortisol production from zona fasciculata

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the signs and symptoms of Cushing’s syndrome

A

Signs and symptoms

> Weight gain
Hirsutism
Psychiatric – euphoria, depression, psychotic symptoms
Proximal myopathy
Moon face with red (plethoric) cheeks
Hypertension
Bruising
Striae (red/purple)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the investigations used to diagnose Cushing’s syndrome

A

Establish cortisol excess
> Dexamethasone suppression testing
> Failure to suppress plasma cortisol
> 24h urinary free cortisol – elevated
> Late night salivary cortisol – elevated

Causes
> ACTH-dependent (ACTH normal/high)
» Pituitary adenoma – Cushing’s disease
» Ectopic ACTH
» Ectopic CRH

> ACTH-independent (ACTH undetectable)
> Adrenal adenoma
> Adrenal carcinoma
> Nodular hyperplasia

> Iatrogenic – prolonged high dose steroid therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the management of Cushing’s syndrome

A

Surgical
> Transphenoidal pituitary surgery
> Laparoscopic adrenalectomy
> Removal of ACTH source

Medical
> Metyrapone/ketoconazole - inhibit cortisol production (short-term measure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe the causes and clinical features of primary adrenal insufficiency

A

Inadequate adrenocortical function

Primary insufficiency - Addison’s disease, autoimmune destruction

Clinical features
> Anorexia, weight loss
> Fatigue / lethargy
> Dizziness and low BP
> Abdominal pain, vomiting, diarrhoea
> Skin pigmentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe how Addison’s disease is diagnosed

A

Biochemistry
> Low sodium, high potassium
> Hypoglycaemia

Short synACTHen test
> Measure plasma cortisol before and 30 minutes after IV ACTH injection

Increased renin, decreased aldosterone

Adrenal autoantibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Describe the pathophysiology, clinical features and treatment of congenital adrenal hyperplasia

A

AR disorder - range of genetic disorders relating to defects in steroidogenic genes

Insufficient aldosterone and cortisol production

Increased drive to produce cortisol and aldosterone, increased ACTH
> Leads to increased DHEA

Most common – CYP21 (21-alpha-hydroxylase)

Female - ambiguous genitalia

Males - adrenal crisis – hypotension, hyponatraemia; early virilisation

Treatment
> Mineralocorticoid and glucocorticoid replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe late onset CAH, including clinical features and diagnosis

A

Partial 21-alpha-hydroxylase deficiency

Maintain cortisol within normal range

Increased ACTH drive leads to increased 17OHP and adrenal androgens

Clinical features
> Oligomenorrhoea
> Hirsutism
> Reduced fertility

Diagnosis - synacthen test with 17-hydroxyprogesterone (17-OHP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Describe primary aldosteronism including its presentation, diagnosis and management

A

Commonest secondary cause of hypertension
> 40% adenoma; 60% bilateral hyperplasia
> Hypokalaemia present in <50% of cases

Aldosterone-renin ratio (ARR) best screening tool

Investigations
> Confirm aldosterone excess
> Stop beta blockers and MR antagonists

> Saline suppression test (should suppress aldosterone)

Management

> Surgical
> Unilateral laparoscopic adrenalectomy
» Only if adrenal adenoma
» Cure of hypokalaemia and in 30-70% cases, hypertension

> Medical
> Use MR antagonists – spironolactone or eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Describe the symptoms, causes and management of a phaeochromocytoma

A

Tumour of adrenal medulla

Symptoms/signs
> Hypertension – intermittent in 50%
> Episodes of headache, palpitations, pallor and sweating
> Tremor, anxiety
> Nausea, vomiting
> Chest or abdominal pain
> Crises last 15 mins (often well in between crises)

Causes

> 25% associated with genetic condition
> MEN – multiple endocrine neoplasia
> VHL – Von Hippel Lindau
> SDHB & SDHD mutations (succinate dehydrogenase)
>Neurofibromatosis

> 15-20% malignant

> 80-85% benign

Management
> Alpha blockade initially
» Phenoxybenzamine or doxazosin

> Then beta blocker if tachycardic
> Labetalol or bisoprolol

> Encourage salt intake

> Surgical removal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Describe adrenal incidentalomas

A

Incidentally discovered adrenal lesion

Discovered through diagnostic imaging for unrelated condition, without prior suspicion of tumour/disease

2 types

> Malignancy
> Size <4 cm
> Lipid rich
> Adenoma rapid washout on dynamic scan

> Functional
> Produce aldosterone, cortisol, androgens, catecholamines…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Describe the production of testosterone

A

Steroid hormone produced in Leydig cells

Circulates bound to SHBG and albumin

Free testosterone is active

Activated to more potent form in target tissues
> Converted to dihydrotestosterone by 5-alpha-reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Describe the production of testosterone

A

Steroid hormone produced in Leydig cells

Circulates bound to SHBG and albumin

Free testosterone is active

Activated to more potent form in target tissues
> Converted to dihydrotestosterone by 5-alpha-reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Describe the effects of testosterone on the body

A

Growth
> Sex organs
> Skeletal muscle
> Epiphyseal plate
> Larynx growth
> Secondary sexual characteristics
> Erythropoiesis
> Behaviour

Adult
> Muscle mass
> Mood
> Bone mass
> Libido
> Body shape

Fertility
> Erectile function
> Spermatogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Describe the endocrine control of gonadal function

A

GnRH released from hypothalamus acts on anterior pituitary
> LH and FSH released from anterior pituitary

LH acts on Leydig cells to produce testosterone

FSH acts on Sertoli cells to aid spermatogenesis
> Sertoli cells also form the blood-testis barrier, remove damaged spermatocytes and secrete androgen-binding protein

Negative feedback loop regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Describe the clinical features associated with male hypogonadism

A

Child / young adult
> Slow growth in teens
> No pubertal growth spurt
> Lack of secondary sexual development

Adult
> Low mood
> Poor libido
> Erectile dysfunction
> Hot flashes / sweats
> Poor muscle bulk / power
> Poor energy
> Sparse body / facial hair
> Gynaecomastia
> Gynoid weight gain
> Short phallus / reduced testicular volumes
> Low trauma fractures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Describe the different types of male hypogonadism

A

Primary hypogonadism

> Hypergonadotrophic hypogonadism
> LH/FSH high + low testosterone

Secondary hypogonadism

> Hypogonadotrophic hypogonadism – hypothalamus or pituitary problem
> LH / FSH normal or low + low testosterone

> > Causes

> > > Pituitary disease e.g. tumour, pituitary surgery or radiotherapy
Head injury
Isolated LH/FSH deficiency – Kallmann’s syndrome
Functional hypothalamic hypogonadism (exercise, weight changes, stress)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Describe Kallman’s syndrome, including pathophysiology and diagnosis

A

Commonest form of isolated gonadotrophin deficiency

Pathophysiology
> Failure of cell migration of GnRH cells to hypothalamus
> Associated with aplasia/hypoplasia of olfactory lobes – giving anosmia or hyposmia
> May be associated with deafness, renal agenesis, cleft lip/palate

Diagnosis
> Anosmia
> Low testosterone, LH/FSH
> Normal pituitary MRI but absent olfactory bulb may be seen

Genetics
> Most commonly isolated gene mutation
» X-linked – absence of KAL gene (KAL1)
» Autosomal dominant (KAL2)
» Autosomal recessive (KAL3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Describe Klinefelter’s syndrome including clinical features, diagnosis and treatment

A

Most common genetic cause of male hypogonadism

Karyotype - 47, XXY or 47, XXY mosaicism

Clinical features
> Delayed puberty
> Reduced testicular volumes
> Reduced secondary male sexual characteristics
> Persistent gynaecomastia
> Azoospermia
> Behavioural issues / learning difficulties
> Psychological support + fertility counselling

> Elevated LH/FSH but seminiferous tubules regress and Leydig cells do not function normally
Low testosterone

Treatment
> Androgen replacement therapy (IM or topical)

> > Side-effects
> Mood issues – aggression/behaviour change
> Libido issues
> Increased haematocrit/polycythaemia
> Development of lower urinary tract symptoms, prostatic enlargement
> Acne
> Gynaecomastia

> Fertility treatment
> hCG
> Recombinant FSH & LH
> GnRH pumps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

State the normal and hyponatraemic ranges of sodium

A

Normal range – 135-145 mmol/L

Serum Na < 135 mmol/L - hyponatraemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Define pseudohyponatraemia and how it may be ruled out as a differential

A

Measure serum osmolality (mOsm/kg) & compare to calculated osmolarity (mOsm/L)

Calculated osmolarity = [2xNa] + Urea + Glucose

Measured = calculated means true hyponatraemia

If not, pseudohyponatraemia – check lipid profile and total protein

Osmolality
- Low - < 275 mOsm/kg of H2O

  • Normal/high - 275-290 mOsm/kg of H2O
    > Exclude
    » Hyperglycaemia
    » Hyperlipidaemia
    » Hyperproteinaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Describe the concept of extracellular hypertonicity

A

Hyponatraemia due to osmotic effect of hyperglycaemia

Na does not require specific treatment

Corrected Na may be calculated
> Corrected Na = [Glu/4] + measured Na

42
Q

Describe the 3 states of true hyponatraemia and how to assess the volume status of a patient

A

Assess volume status of patient
> Pulse
> BP – postural drop
> Urine output / fluid status
> JVP
> Ascite, oedema

3 states

Hypervolaemic – Na and H2O excess; hypotonic

> Urine Na > 20 - acute or chronic renal failure

> Urine Na < 20 - hepatic failure, nephrotic syndrome

Euvolaemic - H2O excess; excessive intake or impaired excretion

> Urine Na > 20
> Urine osmolality <100 – H2O intoxication
> Urine osmolality > 100 – SIADH

Causes
> Glucocorticoid deficiency
> Renal failure
> Hypothyroidism

Hypovolaemic - Na depletion

> Urine Na > 20 - renal losses, diuretic excess, mineralocorticoid deficiency, salt-losing nephropathy

> Urine Na < 20 - extra-renal losses, vomiting, diarrhoea, burns

43
Q

Describe SIADH and its causes

A

Common cause of low Na

Excessive ADH release but patient’s volume is normal - ICF and ECF expanded but no oedema

Inappropriately high urine osmolality (>100 mmol/Kg)

Urine sodium high >20 mmol/L

Diagnosis of exclusion
> Normal renal function
> Normal thyroid function
> Normal adrenal function
> Not on diuretics

Causes
> Pulmonary infections and lesions
> Carcinoma
> CNS disorders
> AIDS
> Post-op pain or stress
> Vomiting
> Drugs: amitryptiline & other TCAs, fluoxetine

44
Q

Describe the treatment of SIADH

A

Volume status
> Hypovolaemic - isotonic saline
> Hypervolaemic - salt and fluid restriction; loop diuretics
> Euvolaemic - free water restriction

Aim
> Increase Na gradually & achieve >120 mmol/L gradually
> If symptomatic may use hypertonic saline (3%)

Pharmacological treatment
> Demeclocycline
» Vasopressin antagonist
» Functional diabetes insipidus (side-effect)

> Aquaretics
> AVP receptor antagonists (vaptins)
> Induce a Na and water diuresis

45
Q

List the symptoms of diabetes

A

Polyuria

Nocturia

Polydypsia

Thirst, dry mouth

Weight loss

Tiredness, fatigue, lethargy

Pruritus vulvae, balanitis (genital candidiasis)

Blurring of vision

Nausea

Headache

Hyperphagia – predilection for sweet foods

Mood change – irritability, difficulty in concentration, apathy

46
Q

Describe the diagnostic criteria for diabetes

A

Fasting plasma glucose - >=7.0 mmol/L

Random (or 2 hour post 75g glucose load) plasma glucose of >=11.1 mmol/L

One abnormal value diagnostic if symptomatic, 2 if asymptomatic

HbA1c >=6.5% or 48 mmol/mol

Diabetes should not be diagnosed on the basis of glycosuria or capillary glucose

47
Q

Describe the classification of diabetes

A

Type 1 diabetes
> Immune pathogenesis; severe insulin deficiency

Type 2 diabetes
> Combination of insulin resistance and insulin deficiency

Other specific types

> Genetic defects of beta cell function – monogenic diabetes

> Genetic defects of insulin action e.g. lipodystrophies

> Pancreatic disease

> Excess endogenous production of hormonal antagonists to insulin
> Growth hormone – acromegaly
> Glucocorticoids – Cushing’s syndrome
> Glucagon – glucagonoma
> Catecholamines – phaeochromocytoma
> Thyroid hormones – thyrotoxicosis

> Drug-induced: glucocorticoids, thiazide diuretics, HIV drugs, immune checkpoint inhibitors

> Genetic syndromes: Down syndrome, Klinefelter’s…

> Gestational diabetes

48
Q

Describe the causes, features and management of pancreatic diabetes

A

Causes
> Pancreatectomy
> Pancreatitis
> Haemochromatosis
> Carcinoma
> Cystic fibrosis

Risk of hypos higher than T1DM due to loss of alpha cells that produce glucagon

Main features
> History of cause (sometimes alcohol history), exocrine dysfunction
> Ketones or acidotic
> C-peptide low but often detectable
> Pancreatic autoantibodies negative

Management: sulphonylurea +/- insulin

49
Q

Describe the cause of monogenic diabetes, its clinical features and management

A

Cause: change in a single gene – monogenic; autosomal dominant inheritance
> HNF1-A responsible for 70% of MODY

Clinical features
> <25 yrs onset
> C-peptide not usually very low
> Pancreatic autoantibodies negative
> Runs in families from one generation to next

Management
> Diet
> Oral antihyperglycaemic agents (OHAs)
> Insulin

50
Q

Describe the pathogenesis of type 1 DM

A

Chronic, progressive metabolic disorder characterised by hyperglycaemia and absence of insulin secretion

Results from autoimmune destruction of insulin-producing beta cells in the islets of Langerhans

Genetic susceptibility + environmental triggers lead to development of type 1 DM

Triggers may include
> Viral infections especially enterovirus
> Dietary toxins – exposure to cow’s milk at an early age
> Vitamin D deficiency
> Hygiene hypothesis
> Immune checkpoint inhibitors

> Markers of autoimmune process
> Anti-GAD
> Anti-IA-2
> Anti-ZnT8

51
Q

Describe the clinical use of C peptide

A

C peptide is secreted in equimolar concentrations to endogenous insulin

Useful marker of endogenous insulin secretion – not a constituent of synthetic insulin

Levels
> <200 pmol/L - severe endogenous insulin deficiency
» T1DM, pancreatic diabetes and MODY
» May be >200 pmol/L in T1DM “honeymoon”

> > 900 pmol/L - increased insulin secretion related to insulin resistance
T2DM but can be lower if some insulin deficiency

> Can be overlap in different types of diabetes

> Can be <600 pmol/L in T2DM if marked hyperglycaemia due to glucotoxicity

52
Q

Describe glucose monitoring

A

Capillary glucose

Continuous glucose monitoring (CGM)
> Tiny sensor inserted under skin to measure interstitial glucose
> Last up to 2 weeks
> Creates an Ambulatory Glucose Profile (AGP)
> Gives estimated HbA1c, target glucose range, high and low thresholds
> Intermittently scanned (flash) or isCGM – every 15 mins
> Real-time or rtCGM – every 5 minutes
> Correlates well with blood glucose but 10-15 minute lag
> Trend arrows and alarms

FreeStyle Libre Device – Flash Glucose Monitoring
> 14 days
> Measures interstitial glucose every minute
> Doesn’t interrupt insulin flow
> Best for trends
> Low and high glucose alarms

53
Q

State the glucose targets diabetic patients should be aiming for

A

HbA1c <53 mmol/L

Before breakfast: 5.5-7 mmol/L

Before other meals: 4.5-7.5 mmol/L

Before bed: 6.5-8 mmol/L

Aim for glucose to rise <2 mmol/L 2h post-bolus

54
Q

Describe the regimes used in insulin delivery

A

Basal bolus
> Intermittent injections, 4x daily
> Basal insulin 1x daily (night)
> Bolus 2x daily – rapid acting insulin with meals
> Resembles physiological insulin release

BD mix regime
> Mixed insulin (1/3 fast acting, 2/3 long acting)
> Requires eating same type of food at same time every day + no exercise or adjustment of routine
> Fewer injections but less physiological

Insulin pumps or continuous subcutaneous insulin infusion (CSII)
> Electronic device containing plastic cartridge of insulin
> Rapid acting insulin only e.g. Novorapid
> Delivers multiple basal rates + multiple boluses

Sensor augmented pump system
> Sensor measures interstitial glucose continuously
> Target range set on smartphone app
> Tells insulin pump how much insulin to deliver
> Still have to input calorie count to calculate bolus insulin

55
Q

Describe the causes and main biochemical features of diabetic ketoacidosis

A

Causes

> At diagnosis when replacement not started

> Underlying illness
> Infections like COVID-19, pneumonia, UTI
> MI & CVA

> Discontinuation of insulin (accidental or deliberate)

> Inadequate insulin delivery - error in admin, pump failure…

> Drugs : SGLT2i, steroid, cocaine

Hyperglycaemia: >11 mmol/L or known diabetes

Hyperketonaemia: >=3.0 mmol/L on fingerprick testing, ketonuria – more than 2+ on urine dipstick

Metabolic acidosis: venous bicarbonate <15 mmol/L, venous pH <7.3, H+ >50 nmol/l

56
Q

Describe the management of DKA and HHS

A

Continue basal insulin

Give fluids (1L 0.9% NaCl over 1 hour) & potassium chloride (KCl)
> Insulin drives potassium into cells
> Risk of hypokalaemia & cardiac arrhythmia

Give further insulin AFTER fluids

57
Q

Describe the biochemical features of hyperglycaemic hyperosmolar state (HHS)

A

Hyperglycaemia: >30 mmol/L

Hyperosmolality: >320 mOsm/kg

Without significant ketonaemia (<3 mmol/L) OR ketonuria (<3+ on urine dipstick) OR metabolic acidosis (venous bicarbonate >15 mmol/L, venous pH >7.3 (H+ < 50 nmol/L) )

58
Q

Compare DKA and HHS

A

DKA
- Type 1 DM; <65y
- Short history
- No residual insulin
- Hyperglycaemia and dehydration
- Acidosis
- Patient alert
- Abdominal pain

HHS
- Type 2 DM; >65y
- Insidious history
- Residual insulin
- Severe hyperglycaemia and profound dehydration
- No acidosis
- Patient drowsy
- Abdo pain uncommon

59
Q

Describe gastroparesis as a complication of diabetes

A

Presents with bloating, indigestion, smelly burps

Associated with hyperglycaemia

Presents with morning nausea

Early satiety due to abnormal and delayed gastric emptying

60
Q

Describe the pathogenesis of type 2 DM

A

Prevalence rises with increasing levels of obesity (BMI > 30) and age

Genetic predisposition combined with weight gain leads to dyslipidaemia

Insulin resistance causes hyperinsulineaemia
> Found in pre-diabetes and early diabetes states

This can result in hypertension, impaired glucose tolerance and impaired fasting glucose

Eventually hyperglycaemia arises, leading to early and then late diabete

61
Q

Describe the goals of type 2 DM treatment as well as biomedical targets for patients

A

Reducing rates of microvascular complications
> Retinopathy, nephropathy, foot disease (ulceration)
> Glycaemic control required

Reducing rates of macrovascular complications
> MI, stroke, heart failure, peripheral vascular disease
> Glycaemic control & managing conventional CV risk factors (smoking, BP, cholesterol)

Biomedical targets

HbA1c - 7% or 53 mmol/mol

BP - <130/80 ; ACEI or ARB, CCB or thiazide diuretic

Cholesterol - statin if aged >40, <5 once started

Healthy body weight

62
Q

List treatments for T2DM

A
  • Lifestyle changes: diet, exercise
  • Metformin
  • Sulphonylureas e.g. gliclazide
  • Thiazolidinediones (pioglitazone))
  • SGLT2 inhibitors e.g. canagliflozin
  • Insulin
  • DPP-4 inhibitors e.g. sitagliptin
  • GLP-1 receptor agonists e.g. liraglutide
63
Q

Describe the mechanism of action, dosage, benefits and side-effects of metformin

A

Mechanism of action
> Suppresses hepatic gluconeogenesis
> Reduces glucose output from liver
> Increases peripheral insulin sensitivity, increasing glucose uptake and utilisation
> Increase AMPK activity

Dosage: 500mg once daily, increase by 500mg until max of 2g

Benefits
> Weight reduction
> Low hypo risk
> CV benefit
> Extensive experience

Side-effects
> GI side effects e.g. diarrhoea, bloating, nausea
> Vitamin B12 deficiency
> Cannot use if eGFR <30
> Small risk of lactic acidosis

64
Q

Describe the mechanism of action, dosage, benefits and side-effects of sulphonylureas

A

Mechanism of action
> Close potassium channel in beta cells stimulating release of stored insulin
> Increased cellular glucose uptake and glycogenesis
> Reduces gluconeogenesis

Benefits
> High efficacy
> Extensive experience

Side-effects
> No CV benefit
> Weight gain
> High hypo risk
> Caution in CKD

65
Q

Describe the mechanism of action, dosage, benefits and side-effects of thiazolidinediones

A

Mechanism of action
> PPAR-gamma receptor antagonists
> Increase sensitivity of fat, muscles and liver to endogenous and exogenous insulin

Benefits
> CV protection
> Low hypo risk

Side-effects
> Weight gain
> Fluid retention
> Fractures

66
Q

Describe the mechanism of action, dosage, benefits and side-effects of insulin

A

Mechanism of action
> Increase glucose uptake and utilisation in skeletal muscle
> Reduced hepatic output, increased glycogenesis
> Decreased lipolysis
> Decreased gluconeogenesis

Benefits
> High efficacy
> Extensive experience

Side-effects
> High hypo risk
> No CV benefit
> Weight gain

67
Q

Describe the mechanism of action, dosage, benefits and side-effects of DPP-4 inhibitors

A

Mechanism of action
> Inhibit DPP-4 and enhance effects of endogenous incretins (GLP-1)
> Increase glucose-mediated insulin secretion, suppress glucagon secretion

Benefits
> Low/moderate efficacy
> Low hypo risk
> Few adverse events

Side-effects
> Weight neutral
> No CV benefit
> Reduce dose in CKD

68
Q

Describe the mechanism of action, dosage, benefits and side-effects of GLP-1 receptor antagonists

A

Mechanism of action
> Increased glucose-mediated insulin secretion
> Suppresses glucagon secretion
> Increases satiety and suppresses appetite

Benefits
> High efficacy
> CV benefit
> Low hypo risk
> Weight loss

Side-effects
> Injected
> GI side effects
> Uncertain safety regarding pancreas

69
Q

Describe the mechanism of action, dosage, benefits and side-effects of SGLT2 inhibitors

A

Mechanism of action
> Inhibit SGLT2 in proximal convoluted tubule of the kidney
> Decrease renal reabsorption of glucose

Benefits
> Moderate efficacy
> CV benefit
> Renal benefit
> Weight loss
> Low hypo risk

Side-effects
> Risk of GU infections
> Small risk of hypovolaemia/DKA

70
Q

Briefly outline the SIGN prescribing guidelines for type 2 diabetes

A

1st line
> Metformin
> Sometimes SU

2nd line
> 2 agents
> Add SU, flozin, gliptin, glitazone

3rd line
> 3 agents
> Add any of the above OR start injectable therapy with GLP-1 agonist or insulin

4th line
> 4 agents from above list

71
Q

Describe prescribing considerations in the elderly, in renal disease and heart failure

A

Elderly
> Polypharmacy with risk of drug interactions
> Increased likelihood of ADRs
> Decrease in eGFR
> Increased likelihood of hypoglycaemia

Renal disease
> Stop metformin when eGFR <30
> Caution with SUs due to hypo risk
> Dose reduction required for some tides and gliptins
> SGLT2 inhibitors less effective at glucose lowering in CKD
> Renal protection – dapagliflozin indicated for CKD

Heart failure
> May use metformin in chronic heart failure but withhold during acute episodes
> Stop or do not initiate glitazone
> Flozins improved outcomes for heart failure with & without diabetes

72
Q

Describe thyroid hormone synthesis

A

Sodium iodine symporter in the luminal membrane takes in and traps iodide from plasma

Iodide secreted through pendrin into colloid and oxidised, becoming iodine
> Target of anti-thyroid drugs

Iodine binds to tyrosine residues on thyroglobulin

Process of organification catalysed by thyroid peroxidase

Results in formation of T4 and T3

TSH stimulates exocytosis of T3 and T4

> T4 – inactive hormone secreted in greater amounts

> T3 – active form
> Converted from T4 by deiodinases in body tissues
> Acts at a nuclear receptor
> Acts on thyroid response elements in gene promoters
> Stimulates/inhibits mRNA and hence protein production

Thyroid hormones circulate in plasma bound to transthyretin, thyroid binding globulin and albumin

73
Q

List functions of thyroid hormones

A

> Metabolism, growth and development
Developmental
Lungs
CNS – myelin, axonal growth
Bone – chondrocytes
Teeth, hair, dermis
CV effects: increased CO, HR, SV, SBP
Stimulates bone turnover
Increases speed of muscle contraction
Stimulates gut motility
Increases glucose usage and glycogenolysis

74
Q

Describe the causes of hyperthyroidism

A

> Autoimmune - Grave’s disease

> TSHoma – pituitary tumour

> Other hormones acting as TSH – HCG
> Often with hyperemesis gravidarum
> Transient thyrotoxicosis
> Requires fluid treatment not thyroid drugs

> Thyroid adenoma

> De Quervain’s thyroiditis – viral trigger

> Excess administration of thyroxine

> Toxic multinodular goitre

> Pregnancy

> Drugs: amiodarone, iodine , thyroxine

75
Q

List symptoms of hyperthyroidism

A

Classical of thyrotoxicosis

Anxiety

Weight loss

Tremor

Heat intolerance

Sweating

Diarrhoea

Tachycardia, AF, warm peripheries

Hypertension

Palpitations

76
Q

Describe amiodarone thyroid disease

A

Type 1 – autoimmune thyrotoxicosis
> Antibody negative
> Treatment – high dose carbimazole

Type 2 – destructive thyroiditis
> Antibody positive
> Treatment – glucocorticoids +/- ATDs

Causes hypo or hyperthyroidism

Amiodarone-induced thyrotoxicosis
> Contains iodine
> Half-life is between 90-120 days, at least 3 months to wear off

77
Q

Describe the thyroid conditions caused by iodine

A

Jod-Basedow phenomenon
> Iodine deplete areas of the world
> Move to area of high iodine prevalence, result in transient iodine-induced hyperthyroidism
> Lasts 2-12 weeks
> Symptomatic treatment e.g. beta-blockers

Wolff-Chaikoff effect
> Iodine-induced hypothyroidism
> Excess iodine transiently inhibits iodide organification
> 10 day duration
> Used for acute treatment of severe thyrotoxicosis – thyroid storm
» Fever and CVS instability
» Untreated thyroid disease

78
Q

Describe the treatment of hyperthyroidism

A

Beta-blockeres

Carbimazole 40 mg daily
> Can cause aplasia cutis in pregnancy

Propylthiouracil (PTU) given in pregnancy

Both inhibit iodine organification by thyroid peroxidase

Side-effects
> Rash / urticaria
> Arthralgia
> Agranulocytosis
> Liver damage in PTU

131I – radioactive iodine

79
Q

Describe thyroid eye disease

A

Exophthalmos (proptosis), diplopia

Lid lag and retraction

Graves’ ophthalmopathy
> Grittiness and redness
> Conjunctival oedema – chemosis
> Periorbital oedema
> Ophthalmoplegia
> Optic neuropathy

80
Q

Describe non-eye signs of thyroid disease

A

Pretibial myxoedema - Rare

Thyroid acropachy
> Club-like fingers
> All 5 digits are enlarged and swollen
> Periosteitis or periosteal reactions present
> Very rare

81
Q

List causes of hypothyroidism

A

Autoimmune thyroiditis
> Hashimoto’s thyroiditis
» Destruction of the thyroid gland (anti thyroid peroxidase (TPO) antimicrosomal antibody)

> Silent

> Post-partum

Viral (often painful)

Thyroidectomy

Following radio-iodine therapy

Drug-induced: amiodarone, lithium, sunitinib

Pituitary disease (hypopituitarism)
> Secondary hypothyroidism

Severe iodine deficiency

Inborn errors – congenital hypothyroidism
> Causes
» Thyroid dysgenesis (85%) - TSH receptor
» Dyshormonogenesis
»> Thyroid peroxidase
»> Thyroglobulin
»> Sodium iodide symporter
»> Pendrin (Pendred syndrome)

Maternal thyroid disease
> Neonatal hypothyroidism

82
Q

List the presentation of neonatal hypothyroidism

A

Cretinism

Coarse facial features

Macroglossia

Large fontanelles

Umbilical hernia

Mottled, cool and dry skin

Developmental delay

Pallor

Myxoedema

Goitre

83
Q

List signs and symptoms and treatment of hypothyroidism

A

Symptoms
> Weight gain
> Depression
> Lethargy
> Constipation
> Cold intolerance
> Poor concentration
> Hoarseness
> Menorrhagia

Signs
> Bradycardia
> Goitre
> Dry skin
> Coarse thin hair
> Anaemia
> Slow relaxing reflexes

Treatment - Levothyroxine (L thyroxine – T4)

84
Q

Describe thyroid nodules, their investigation and treatment

A

Common, potential thyroid cancers

Investigations
> Ultrasound
> Fine needle aspiration biopsy

Thyroid tumours

> Follicular cell
> Benign adenoma
> Papillary cancer
> Follicular cancer
> Anaplastic cancer
> Poorly differentiated

> C cell
> Medullary cancer

Treatment
> Fine needle aspiration of nodules
> Surgery
> Therapeutic radioiodine
> Suppression of TSH if TSH-dependent
> Monitoring of thyroglobulin

85
Q

List the different types of insulin preparations

A

Rapid – Novorapid

Short-acting – Humulin S, Actrapid

Intermediate – Insulatard, Humulin I

Long-acting – Lantus, Levemir

Rapid acting-intermediate mixture – Humalog Mix 25
> 25% rapid acting insulin

Short acting-intermediate mixture – Humulin M3

86
Q

List features of thyroid storm

A

Fever
Marked tachycardia
Heart failure
Tremor
Nausea and vomiting
Diarrhoea
Dehydration
Restlessness
Extreme agitation
Delirium
Coma

87
Q

Describe the education given to diabetic patients

A

Glucose / ketone monitoring

Insulin administration
> Rotate administration site to avoid lipodystrophy

Carbohydrate counting and insulin management

Sick day rules
> Check blood glucose and ketones
> Sip sugar-free fluids
> Continue taking basal insulin + bolus insulin if necessary

Hypoglycaemia

Driving regulations
> Check blood glucose before driving
> If hypoglycaemic, eat and wait 45 mins then re-check
> If long drive - check blood glucose every 2 hours
> Check frequency of hypoglycaemia, retinopathy?, awareness of hypoglycaemia, diabetic control
> Do they drive for a living?
> Alert DVLA

Exercise & alcohol

Pregnancy

Targets

Complications

DAFNE – dose adjustment for normal eating

88
Q

Describe autoimmune polyendocrine syndrome type 2

A

Triad of Addison’s, autoimmune thyroiditis, and T1DM
More common in females
Presents in adulthood
Polygenic
- HLA DQ/DR allele association
Associations with
- pernicious anemia
- primary hypogonadism
- myasthenia gravis
- coelic disease
- alopecia
- stiff man syndrome

89
Q

Discuss why signs of mineralocorticoid excess and cortisol excess is a red flag

A

The adrenal hormones are similar molecularly – as a consequence cortisol and aldosterone can activate the same receptors – both have affinity for the receptors

Cortisol is made at greater conc than aldosterone in health – why doesn’t it just override the aldosterone and give us all hypertension – the reason this doesn’t happen is due to 11BHSD (11 beta hydroxysteroid dehydrogenase) (enzyme) being co-located on the MR – this changes cortisol to the inactive cortisone – prevents cortisol from illicitly activating the MR

Overwhelming/huge levels of cortisol overwhelms the 11 BHSD allow cortisol to illicitly activate the MR and give signs of cortisol excess and mineralocorticoid excess – big red flag (sounds like cortisol coming from an ectopic ATCH – rather than pituitary adenoma or adrenal lump – as the levels are too high)
- ATCH should be done for diagnosis

90
Q

State how to differentiate gynacomastia from normal fatty tissue due to obesity

A
  • Gynecomastia will have harder tissue around the nipple compared to just fat
91
Q

List reasons to suspect a pheochromocytoma/ paraganglioma

A

SHDB/D = suxate dehydrogenase

92
Q

State biochemical testing for pheochromocytoma/ paraganglioma

A

measurement of free plasma metanephrines or measurement of urine fractionated metanephrines

93
Q

List medications which may cause falsely elevated free plasma metanephrines/urine fractionated metanephrines

A
94
Q

State the pharmacological treatment of prolactinoma and the potential mental health side effect

A

Prolactinoma is treated with dopamine agonists (cabergoline)
- Can be associated with mood disorders particularly impulsive disorders

95
Q

State the effects of metformin

A
  • suppresses hepatic gluconeogenesis, reducing glucose output from the liver
  • increases peripheral insulin sensitivity, increasing glucose uptake and utilisation
  • increases AMPK activity
96
Q

List conditions which cause lower than expected HbA1c (looks like better control)

A

Decreases RBC lifespan

Sickle-cell anaemia
GP6D deficiency
Hereditary spherocytosis
Haemodialysis

97
Q

List conditions which cause higher than expected HbA1c (looks like worse control)

A

Increases RBC lifespan

Vitamin B12/folic acid deficiency
Iron-deficiency anaemia
Splenectomy

98
Q

List test results in the diagnosis of diabetes if a) symptomatic b) asymptomatic

A

If symptomatic one of the following results is sufficient:
If asymptomatic need two results required from different days:
Random blood glucose= above 11.1mmol/l
Fasting plasma glucose= above 7mmol/l
2 hour glucose tolerance= above 11.1mmol/l
HbA1C= above 48mmol/mol (6.5%)​

99
Q

List symptoms of DKA

A

DKA is Deadly

Delirium/pyschosis
Kussmaul breathing
Abdominal pain/nausea/vomiting
Dehydration

100
Q

Summarise primary, secondary and tertiary hyperparathyroidism

A
101
Q

Discuss Rotterdam diagnostic criteria

A

Rotterdam diagnostic criteria
Assuming that other causes have been excluded, PCOS can be diagnosed if two of the following are present:
Polycystic ovaries (>12 cysts seen on imaging or ovarian volume >10 cubic cm)
Oligo-/anovulation
Clinical or biochemical features of hyperandrogenism